Loading…
Loading…
bioMérieux S.A. (BMXXY) Q1 2026 Sales/Trading Call Transcript
HealthEquity (NASDAQ: HQY - Get Free Report) and bioMerieux (OTCMKTS:BMXMF - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Institutional and Insider Ownership 99.6% of HealthEquity shares are held
Shares of bioMerieux (OTCMKTS:BMXMF - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $109.61, but opened at $115.00. bioMerieux shares last traded at $115.00, with a volume of 1,012 shares trading hands. Analysts Set New Price Targets Separately, BNP Paribas Exane cut shares of bioMerieux to
bioMérieux S.A. (BMXXY) Q4 2025 Earnings Call Transcript
bioMérieux S.A. (OTCPK:BMXXY) Analyst/Investor Day November 4, 2025 8:30 AM EST Company Participants Aymeric Fichet Pierre Boulud - Chief Executive Officer Guillaume Bouhours - Executive VP of Purchasing and Information Systems & CFO Conference Call Participants Odysseas Manesiotis - BNP Paribas, Research Division Anchal Verma - JPMorgan Chase & Co, Research Division Aisyah Noor - Morgan Stanley, Research Division Dylan van Haaften - Stifel, Nicolaus & Company, Incorporated, Research Division Jan Koch - Deutsche Bank AG, Research Division Natalia Webster - RBC Capital Markets, Research Division Kavya Deshpande - UBS Investment Bank, Research Division Presentation Operator Welcome to the bioMérieux 2025 Third Quarter Sales Conference Call.
bioMérieux S.A. (OTCPK:BMXMF) Q4 2024 Results Conference Call March 7, 2025 8:00 AM ET Company Participants Aymeric Fichet - Investor Relations Pierre Boulud - Chief Executive Officer Guillaume Bouhours - Chief Financial Officer Conference Call Participants Aisyah Noor - Morgan Stanley Odysseas Manesiotis - BNP Paribas Marianne Bulot - Bank of America Maja Pataki - Kepler Natalia Webster - RBC Ed Hall - Stifel Jan Koch - Deutsche Bank Kavya Deshpande - UBS Operator Good day, and welcome to the bioMérieux Fourth Quarter Sales and Full Year 2024 Results Conference Call.
bioMérieux S.A. (OTCPK:BMXMF) Q2 2024 Results Conference Call September 5, 2024 8:00 AM ET Company Participants Aymeric Fichet - IR Pierre Boulud - Chief Executive Officer Guillaume Bouhours - CFO Conference Call Participants Hugo Solvet - Exane BNP Paribas Maja Pataki - Kepler-Chevreux Aisyah Noor - Morgan Stanley Kavya Deshpande - UBS Jan Koch - Deutsche Bank Marianne Bulot - Bank of America Operator Good day, and welcome to the H1 2024 Results Conference Call.
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript
No recent filings indexed.